4//SEC Filing
Thiara Parvinder 4
Accession 0001209191-23-053670
CIK 0001827506other
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 4:46 PM ET
Size
7.2 KB
Accession
0001209191-23-053670
Insider Transaction Report
Form 4
Thiara Parvinder
Director
Transactions
- Purchase
Common Stock
2023-10-24$10.66/sh+5,000$53,300→ 80,782 total - Purchase
Common Stock
2023-10-25$12.12/sh+2,000$24,240→ 82,782 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.13 to $10.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.95 to $12.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Tourmaline Bio, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001995535
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 4:46 PM ET
- Size
- 7.2 KB